YOLFTbeta
Panion & BF Biotech Inc

Panion & BF Biotech Inc

1760 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

47.55TWD+0.15 (+0.32%)

Price History

Full chart

Market Stats

Previous Close47.40
Open47.65
Day Range47.40 – 48.50
52-Week Range53.40 – 74.16
Volume117.15K
Market Cap4.68B
P/E (TTM)21.84
Forward P/E0.00
EPS2.50
Dividend Yield3.30%
Beta-0.11
50-Day Avg56.99
200-Day Avg61.25

About

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Tsung-Ming Chiang
  • Employees0
  • HeadquartersNo. 3, Yuanqu Street, Taipei, Taiwan, 11503, Taiwan
  • Websitehttps://www.pbf.com.tw

Leadership

  • Mr. Tsung-Ming ChiangGM & Director
  • Feng-Jen WangFinancial Director
  • Mei-Lun ChiuAccounting Supervisor
  • Zong Huai LuDeputy General Manager
  • Raymond ChuangAssociate Director of Innovative Healthcare Division
  • Ken ChianAssociate Director of Innovative Diagnostics Division
  • Nick C.C. TsaiDeputy GM & Spokesperson of the Operations Management Department

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue559.40M524.78M584.25M674.90M857.08M1.01B1.21B1.05B1.21B1.41B1.57B1.57B1.90B2.40B1.88B2.03B2.06B
Growth (%)--6.19%+11.33%+15.52%+26.99%+18.36%+18.80%-12.93%+15.56%+16.19%+11.73%-0.34%+21.20%+26.16%-21.54%+7.85%+1.66%
Cost of Revenue262.18M230.92M282.52M326.96M392.28M405.33M469.17M460.76M518.10M605.36M709.64M754.61M989.07M1.08B907.48M959.37M946.54M
Gross Profit297.22M293.86M301.73M347.94M464.81M609.07M735.89M588.48M694.38M803.38M864.31M814.03M912.14M1.32B974.40M1.07B1.12B
Gross Margin53.13%56.00%51.64%51.55%54.23%60.04%61.07%56.09%57.27%57.03%54.91%51.89%47.98%54.97%51.78%52.73%54.13%
Operating Expense293.29M349.25M349.15M395.65M450.93M544.67M615.93M458.86M549.66M591.41M636.20M716.72M712.72M977.52M817.57M864.61M809.00M
Operating Income3.92M-55.39M-47.42M-47.71M13.88M64.40M119.97M129.62M144.72M211.97M228.11M97.32M199.42M341.07M156.83M205.67M307.85M
Operating Margin0.70%-10.56%-8.12%-7.07%1.62%6.35%9.96%12.35%11.94%15.05%14.49%6.20%10.49%14.22%8.33%10.13%14.92%
EBITDA40.11M-12.67M-13.97M-15.54M51.50M90.28M152.81M171.82M186.32M253.74M296.48M181.46M343.05M504.62M327.22M405.32M446.27M
EBITDA Margin7.17%-2.41%-2.39%-2.30%6.01%8.90%12.68%16.38%15.37%18.01%18.84%11.57%18.04%21.04%17.39%19.97%21.63%
Net Income5.09M-39.30M-36.26M-40.56M18.15M48.27M73.00M89.72M90.54M159.17M161.33M27.90M104.40M182.34M77.22M124.52M190.17M
Net Income Margin0.91%-7.49%-6.21%-6.01%2.12%4.76%6.06%8.55%7.47%11.30%10.25%1.78%5.49%7.60%4.10%6.14%9.22%
R&D25.17M52.55M50.58M48.63M38.70M57.99M80.06M67.77M103.64M110.69M103.42M127.02M157.71M248.50M217.04M236.88M195.46M
R&D as % of Total Revenue4.50%10.01%8.66%7.21%4.52%5.72%6.64%6.46%8.55%7.86%6.57%8.10%8.30%10.36%11.53%11.67%9.47%
Interest Expense5.83M5.68M6.26M6.71M5.10M11.00K72.00K334.00K117.00K63.00K1.83M4.46M14.68M7.58M11.36M15.02M14.34M
Interest Expense % of Total Revenue1.04%1.08%1.07%0.99%0.60%0.00%0.01%0.03%0.01%0.00%0.12%0.28%0.77%0.32%0.60%0.74%0.70%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets873.43M861.72M934.09M924.20M1.00B1.11B1.18B1.19B1.25B1.83B1.91B3.07B2.95B3.09B3.24B3.21B3.23B
Total Liabilities548.82M560.10M637.11M645.34M343.99M397.15M400.33M384.82M412.15M484.38M552.94M1.83B1.02B1.09B1.32B1.29B1.27B
Total Equity292.94M284.73M289.41M272.48M656.55M710.84M775.03M806.41M835.25M1.35B1.36B1.24B1.93B2.01B1.91B1.92B1.95B
Cash134.25M109.49M80.78M73.15M148.35M164.99M127.77M187.99M221.51M595.69M364.86M310.11M279.10M464.26M534.63M558.37M460.32M
Total Debt209.76M303.79M346.44M339.31M-1.08M----111.01M1.24B502.56M482.33M727.83M704.86M647.70M
Net Debt75.51M194.29M265.66M266.16M-148.35M-163.90M-127.77M-187.99M-221.51M-595.69M-253.85M929.21M223.46M18.07M193.21M146.49M187.39M

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow76.98M-13.89M-36.12M3.96M86.22M76.11M58.30M177.22M113.97M78.58M90.98M-14.55M401.23M489.87M177.42M351.19M298.71M
Investing Cash Flow-12.09M-175.74M-37.71M-27.67M-27.08M-89.27M-90.45M-67.49M-20.26M-55.45M-160.83M-686.61M-215.05M-144.47M-155.27M-158.77M-133.37M
Financing Cash Flow-12.14M170.41M43.52M17.55M13.99M22.41M-3.68M-40.61M-55.44M355.27M-160.50M643.21M-217.76M-167.39M48.67M-170.51M-262.85M
Capital Expenditure15.55M187.47M37.42M26.63M19.59M73.12M64.60M77.88M25.29M39.23M82.18M101.16M170.01M198.64M181.23M185.69M148.34M
Free Cash Flow61.43M-201.36M-73.54M-22.67M66.64M2.99M-6.29M99.33M88.68M39.36M8.80M-115.72M231.22M291.23M-3.81M165.49M150.37M
Dividends Paid------7.27M45.00M55.75M115.11M138.13M138.13M53.72M128.61M171.48M128.61M154.33M
FCF to OCF79.80%1449.16%203.60%-572.71%77.28%3.93%-10.79%56.05%77.81%50.08%9.68%795.02%57.63%59.45%-2.15%47.12%50.34%
Dividend Paid to FCF-------115.51%45.30%62.87%292.48%1568.77%-119.37%23.23%44.16%-4497.19%77.71%102.63%

Earnings

Report DateMay 10, 2017Aug 10, 2017Nov 29, 2017Mar 26, 2018May 11, 2018Aug 14, 2018Nov 13, 2018Feb 27, 2019May 14, 2019Aug 13, 2019Nov 13, 2019Mar 27, 2020May 14, 2020Aug 13, 2020Nov 13, 2020Mar 17, 2021May 13, 2021Aug 12, 2021Nov 11, 2021Mar 26, 2022May 11, 2022Aug 11, 2022Nov 14, 2022Mar 30, 2023May 11, 2023Aug 10, 2023Nov 14, 2023Mar 7, 2024Aug 13, 2024Nov 13, 2024Mar 7, 2025
EPS Estimate----0.370.530.47-0.260.740.181.320.450.270.900.570.190.991.121.020.540.850.831.731.930.791.401.100.330.370.39
EPS Actual0.460.220.380.210.070.530.291.180.520.600.240.730.01-0.10-0.040.49-0.310.970.77-0.100.461.880.91-1.130.260.200.090.350.230.320.38
Surprise-----81.08%0.00%-38.30%-100.00%-18.92%33.33%-44.70%-97.78%-137.04%-104.44%-14.04%-263.16%-2.02%-31.25%-109.80%-14.81%121.18%9.64%-165.32%-86.53%-74.68%-93.57%-68.18%-30.30%-13.51%-2.56%
TimingPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap4.68B
Enterprise Value4.75B
Trailing P/E21.84
Forward P/E0.00
Price / Sales2.22
Price / Book2.47
EPS2.50
Book Value21.86
Revenue (TTM)2.11B
Gross Profit (TTM)1.11B
EBITDA430.81M
Profit Margin10.19%
Operating Margin12.09%
Return on Equity11.63%
Return on Assets6.17%
Shares Outstanding85.74M
Shares Float66.64M
Beta-0.11
Dividend Yield3.30%
Dividend Rate1.80
Payout Ratio72.07%

Dividends

20261×
1.80Jun 11, 2026
20251×
1.80Jun 12, 2025
20241×
1.50Jun 13, 2024
20231×
2.00Jul 18, 2023
20221×
1.50Jun 27, 2022
20211×
0.69Jun 24, 2021
20201×
1.77Jun 30, 2020
20191×
1.77Jun 27, 2019
20181×
1.48Jun 19, 2018
20171×
0.81Jul 14, 2017
20161×
0.65Jul 29, 2016
20151×
0.11Sep 3, 2015

Stock Splits

  • Jul 14, 20171100:1000
  • Jul 29, 20161099.876:1000
  • Sep 3, 20151160:1000
  • Aug 28, 20141099.591:1000